Skip to main content
Clinical Trials/KCT0006636
KCT0006636
Recruiting
未知

A clinical trial designed to verify the effectiveness of a low-level medical laser apparatus TINI” in improving tinnitus symptoms of chronic high-frequency tinnitus patients

WONTECH0 sites56 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the ear and mastoid process
Sponsor
WONTECH
Enrollment
56
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
WONTECH

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged \= 19 years
  • 2\. Unilateral subjective tinnitus symptoms for more than 3 months (If the subject has bilateral tinnitus, subject who has dominant symptom between two ears could be enrolled.)
  • 3\. A person with a tinnitogram of at least 4 kHz tinnitus frequency
  • 4\. Consent to and willing to discontinue medication for tinnitus (eg, Ginkgo\-Biloba, Tanamin, etc.) during this trial
  • 5\. Women of childbearing age who are confirmed by negative in pregnancy test and who agree to use the contraceptive device during the study
  • 6\. Those who agree not to receive any treatment on the ear during the period of clinical trial participation
  • 7\. Those who voluntarily participate in the trial and are willing to follow the protocol
  • 8\. Those who have fully understood the written consensus

Exclusion Criteria

  • 1\. In the cases that the tinnitus has definite cuase (acoustic neurinoma, cerebral tumor, cerebral vessel malformation, vascular tinnitus, tinnitus induced by muscle contraction)
  • 2\. Those with history of conductive hearing loss, perforation of the eardrum, etc.
  • 3\. Experiences of ototoxic drugs, those who have had meningitis
  • 4\. Those who have ear diseases such as external otitis, ear canal occlusion, otitis media
  • 5\. Any person who has had a serious disease in cardiovascular, digestive, respiratory, endocrine, or central nervous system, or a mental illness
  • 6\. Anyone who is sensitive to light
  • 7\. Women of childbearing age who do not agree to contraception during the study
  • 8\. Pregnant women or nursing woman
  • 9\. Persons who participated in other clinical trials within 30 days prior to screening
  • 10\. Other persons deemed inappropriate to participate in this clinical trial at the discretion of the researcher

Outcomes

Primary Outcomes

Not specified

Similar Trials